- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07942961
Evaluation of a Values-Clarification Tool for Older Adults With Cancer
This randomized pilot study will evaluate whether a decision support tool can improve values clarification and shared decision-making (SDM) among older adults with advanced-stage cancer. The tool, developed previously, helps patients identify their personal values and provides tailored feedback and relevant questions to support treatment discussions. Participants will be randomly assigned to intervention or control groups and take part in simulated patient-clinician consultations. The study aims to assess and compare the quality of values clarification and SDM processes between the two groups.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
North Carolina
-
Chapel Hill, North Carolina, Forente stater, 27599
- University of North Carolina at Chapel Hill, Department of Radiation Oncology
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- Subjects is willing and able to comply with study procedures based on the judgement of the investigator.
- Age is 60 years or above at the time of consent (patients).
- Current or previous cancer diagnosis at advanced stage, not limited by site.
Exclusion Criteria:
- Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention group
Participants assigned to the intervention group will receive the values-clarification decision support tool, which guides them in identifying their personal values, preferences, and priorities regarding cancer treatment. The tool also provides tailored feedback and relevant questions to help participants communicate their preferences and support discussions with the clinician during simulated consultations. |
Participants assigned to the intervention group will receive a decision support tool designed for older adults with advanced-stage cancer. The tool helps participants identify and clarify their personal values, preferences, and priorities regarding cancer treatment. It also provides tailored feedback and relevant questions from question prompt lists (QPLs) to support communication and shared decision-making during simulated clinical consultations. |
|
Aktiv komparator: Control group
Participants receive contextualized cancer-related educational information from the American Cancer Society and do not receive the values-clarification decision support tool. |
Participants will receive contextualized cancer-related educational information from the American Cancer Society. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Quality of Values Clarification
Tidsramme: Baseline, Up to 1 hour
|
The primary endpoint is the quality of values-clarification processes during simulated clinical consultations, measured using a standardized checklist developed by the study team. Checklist scores will range from 0 to 100, with higher scores indicating better quality of values clarification. Scores will be compared between participants who receive the values-clarification decision support tool (intervention group) and those who receive American Cancer Society educational information (control group), overall and stratified by consultation type (values-based and non-values-based). Higher scores indicate better quality. |
Baseline, Up to 1 hour
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Participants' Perceptions of the Decision Support Tool and Shared Decision-Making
Tidsramme: Baseline, Up to 1 hour
|
Participants' perceptions will be assessed through semi-structured interviews and questionnaires to evaluate: (1) their experiences and perceptions of receiving tailored feedback and content-matched questions based on their stated values; (2) their perceptions of the values-clarification process; and (3) their perceptions of shared decision-making (SDM) during simulated clinical consultations. |
Baseline, Up to 1 hour
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Daniel R Richardson, MD, MA, MSc, UNC Lineberger Comprehensive Cancer Center
Publikasjoner og nyttige lenker
Hjelpsomme linker
- <p>University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials</p>
- <p>Advancing Knowledge of Values-Clarification Processes During Complex Decision-Making Among Older Adults With Advanced Cancer: Protocol for a Pilot Randomized Trial Using Simulated Patient-Clinician Encounters</p>
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- LCCC2331
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .